Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | February 17, 2021 | News story | Research and Development |Â Â COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundupÂ
The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all adults, the Pfizer-BioNTech shot has been proven 94% effective in a major study of 1.2 million people, and South Korea have ramped up their vaccination programme by ordering doses for 23 million more people.
1. WHO panel recommends AstraZeneca COVID-19 vaccine for over-65s – Published 11/02/2021
Scientists advising the WHO have recommended the use of the Oxford-AstraZeneca COVID-19 vaccine in all adults, including those aged over 65.
2. AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances – Published 12/02/21
Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated assurances that it is safe and effective.
3. Pfizer COVID-19 vaccine proven 94% effective in biggest study yet – Published 15/02/21
The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the shot’s efficacy.
4. South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines – Published – 16/02/21
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
5. WHO approves two versions of AstraZeneca’s COVID-19 vaccine – Published 16/02/21
The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled out globally through COVAX.
Related Content
BioNet receives positive EMA opinion on new pertussis vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use …
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
